President: David S. Cantor, Ph.D.
Dr. David Cantor is the CEO and managing partner of BrainDx.
He holds a Bachelors Degree with Distinction in Psychology from the University of Connecticut, Honors work in the field of neurophysiological correlates of cross modal integration processes in attention deficit disorders, and Masters and Doctorates in Psychology at the State University of New York at Stony Brook where his dissertation work was on quantitative EEG correlates of Autism.
He also holds a post-doctoral Masters of Science Degree in Psychopharmacology from Farleigh Dickinson University.
He holds Diplomate or Fellow status with many clinical and research societies in the field of psychology and clinical neuroscience and has been a former President of the EEG and Clinical Neuroscience Society.
He has been accepted for special fellowships including Congressional Fellow of the American Psychological Association and the State of New York Intercampus Fellow in the area of Brain Research.
is among the pioneers in the clinical use of this technology and is a nationally recognized expert in the field.
uses the technology in his
practice in Atlanta, Georgia now, and consults with other many professionals nationally and internationally to help them use the technology more effectively.
has overseen an estimated 20,000 clinical QEEG reports spanning many clinical applications in fields of neurotrauma, neurology, psychiatry, and neuropsychology.
This experience gives him a somewhat unique perspective on the potential uses of the BrainDx
technology, and his
management experience with his
own practice and a history of businesses using QEEG helps oversee the operations of BrainDx.
Applying advanced methods in clinical practice.
In Budzynski, T, Budzynski, H., Evans, J. and Abarbanel, A. Introduction to Quantitative EEG
and Neurofeedback: Advance Theory and Applications, 2nd Ed.
, 2009, 63-81.
, D. & Evans, J. (Eds.) Clinical Methods of Neurotherapy: Techniques and Treatment Applications.
, In press, 2013.